• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在一个来自初级保健的大型炎性多关节炎患者队列中,导致住院的感染风险及预测因素。

Risk and predictors of infection leading to hospitalisation in a large primary-care-derived cohort of patients with inflammatory polyarthritis.

作者信息

Franklin Jarrod, Lunt Mark, Bunn Diane, Symmons Deborah, Silman Alan

机构信息

Epidemiology Research Unit, Manchester University Medical School, Manchester M13 9PT, UK.

出版信息

Ann Rheum Dis. 2007 Mar;66(3):308-12. doi: 10.1136/ard.2006.057265. Epub 2006 Sep 19.

DOI:10.1136/ard.2006.057265
PMID:16984941
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1856002/
Abstract

BACKGROUND

The increased mortality observed in patients with rheumatoid arthritis is partly due to an increased occurrence of serious infections. A retrospective study from the Mayo Clinic found that infection risk is increased in rheumatoid arthritis. In particular, serious infection was associated with severe disease and use of corticosteroids. Robust estimates are required from prospective studies of incident cases.

OBJECTIVE

To examine the risk of infection leading to hospitalisation and potential factors associated with this risk in an unselected population of patients with inflammatory polyarthritis.

DESIGN

A prospective cohort study comparing infection incidence in new-onset patients with inflammatory polyarthritis with local population experience.

PATIENTS AND METHODS

2108 patients with inflammatory polyarthritis from a community-based register were studied and followed up annually (median 9.2 years). The rate of hospitalisations for serious infection was compared with the rate of hospitalisations in the regional population. The contribution of potential predictors was assessed by undertaking a within-cohort analysis.

RESULTS

Overall, the incidence of infection was more than two and a half times that of the general population (varying by site). History of smoking, corticosteroid use and rheumatoid factor were found to be significantly independent predictors of infection-related hospitalisation. Patients with inflammatory polyarthritis with all three factors were more than seven times as likely to be hospitalised compared with the rest of the cohort.

DISCUSSION

These findings provide background data on the risk of infection associated with rheumatoid arthritis, and are of particular interest given the current awareness of the risk of infection associated with anti-tumour necrosis factoralpha treatments.

摘要

背景

类风湿关节炎患者死亡率增加部分归因于严重感染发生率上升。梅奥诊所的一项回顾性研究发现类风湿关节炎患者感染风险增加。特别是,严重感染与疾病严重程度及使用皮质类固醇有关。需要对新发病例进行前瞻性研究以得出可靠估计。

目的

在未选择的炎性多关节炎患者人群中,研究导致住院的感染风险及与此风险相关的潜在因素。

设计

一项前瞻性队列研究,比较炎性多关节炎新发病例的感染发生率与当地人群情况。

患者和方法

对来自社区登记处的2108例炎性多关节炎患者进行研究,并每年随访(中位时间9.2年)。将严重感染的住院率与该地区人群的住院率进行比较。通过队列内分析评估潜在预测因素的作用。

结果

总体而言,感染发生率是普通人群的两倍半以上(因感染部位而异)。吸烟史、使用皮质类固醇和类风湿因子被发现是感染相关住院的显著独立预测因素。具有这三个因素的炎性多关节炎患者住院可能性是队列其他患者的七倍以上。

讨论

这些发现提供了与类风湿关节炎相关的感染风险的背景数据,鉴于目前对抗肿瘤坏死因子α治疗相关感染风险的认识,这些发现尤其令人关注。

相似文献

1
Risk and predictors of infection leading to hospitalisation in a large primary-care-derived cohort of patients with inflammatory polyarthritis.在一个来自初级保健的大型炎性多关节炎患者队列中,导致住院的感染风险及预测因素。
Ann Rheum Dis. 2007 Mar;66(3):308-12. doi: 10.1136/ard.2006.057265. Epub 2006 Sep 19.
2
Incidence of lymphoma in a large primary care derived cohort of cases of inflammatory polyarthritis.在一个源自大型初级保健机构的炎性多关节炎病例队列中淋巴瘤的发病率。
Ann Rheum Dis. 2006 May;65(5):617-22. doi: 10.1136/ard.2005.044784. Epub 2005 Oct 25.
3
High disease activity is associated with an increased risk of infection in patients with rheumatoid arthritis.高疾病活动度与类风湿关节炎患者的感染风险增加有关。
Ann Rheum Dis. 2011 May;70(5):785-91. doi: 10.1136/ard.2010.128637. Epub 2011 Feb 2.
4
The comparative risk of serious infections among rheumatoid arthritis patients starting or switching biological agents.类风湿关节炎患者起始或转换生物制剂治疗后的严重感染风险比较。
Ann Rheum Dis. 2011 Aug;70(8):1401-6. doi: 10.1136/ard.2010.146365. Epub 2011 May 17.
5
Excess risk of hospital admission for cardiovascular disease within the first 7 years from onset of inflammatory polyarthritis.炎症性多关节炎发病后 7 年内心血管疾病住院的超额风险。
Ann Rheum Dis. 2010 Sep;69(9):1660-4. doi: 10.1136/ard.2009.121871. Epub 2010 May 24.
6
Opportunistic infections in rheumatoid arthritis patients exposed to biologic therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.类风湿关节炎患者接受生物治疗后的机会性感染:英国风湿病学会类风湿关节炎生物制剂登记处的研究结果。
Rheumatology (Oxford). 2018 Jun 1;57(6):997-1001. doi: 10.1093/rheumatology/key023.
7
The influence of systemic glucocorticoid therapy upon the risk of non-serious infection in older patients with rheumatoid arthritis: a nested case-control study.全身糖皮质激素治疗对老年类风湿关节炎患者非严重感染风险的影响:一项巢式病例对照研究。
Ann Rheum Dis. 2011 Jun;70(6):956-60. doi: 10.1136/ard.2010.144741. Epub 2011 Feb 1.
8
Risk of serious infections in tocilizumab versus other biologic drugs in patients with rheumatoid arthritis: a multidatabase cohort study.托珠单抗与其他生物制剂治疗类风湿关节炎患者的严重感染风险:多数据库队列研究。
Ann Rheum Dis. 2019 Apr;78(4):456-464. doi: 10.1136/annrheumdis-2018-214367. Epub 2019 Jan 24.
9
Association of methotrexate and tumour necrosis factor antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registry.在 CORRONA 注册研究中,甲氨蝶呤和肿瘤坏死因子拮抗剂与包括机会性感染在内的感染结局(包括感染性结局)风险的相关性。
Ann Rheum Dis. 2010 Feb;69(2):380-6. doi: 10.1136/ard.2008.089276. Epub 2009 Apr 8.
10
Risk of septic arthritis in patients with rheumatoid arthritis and the effect of anti-TNF therapy: results from the British Society for Rheumatology Biologics Register.类风湿关节炎患者发生脓毒性关节炎的风险和抗 TNF 治疗的效果:来自英国风湿病学会生物制剂注册处的结果。
Ann Rheum Dis. 2011 Oct;70(10):1810-4. doi: 10.1136/ard.2011.152769. Epub 2011 Jul 21.

引用本文的文献

1
Identifying the genetic association between rheumatoid arthritis and the risk of infectious diseases.确定类风湿性关节炎与传染病风险之间的遗传关联。
Clin Rheumatol. 2025 May 16. doi: 10.1007/s10067-025-07485-x.
2
Longitudinal risk of serious infections in patients with inflammatory arthritis on immunomodulating therapy compared to controls.与对照组相比,接受免疫调节治疗的炎性关节炎患者发生严重感染的纵向风险。
Rheumatol Adv Pract. 2025 Feb 12;9(1):rkaf017. doi: 10.1093/rap/rkaf017. eCollection 2025.
3
Risk Factors for Postoperative Urinary Tract Infection in Patients Undergoing Arthrodesis for Spinal Deformity of Different Levels.不同节段脊柱畸形融合手术患者术后尿路感染的危险因素
Int J Spine Surg. 2025 Jun 12;19(3):296-301. doi: 10.14444/8724.
4
Evaluation of the BIOSECURE Questionnaire in Patients Followed for Inflammatory Rheumatological and Gastrointestinal Diseases Through the Analysis of This Questionnaire.通过对生物安全问卷的分析评估该问卷在炎症性风湿性和胃肠道疾病患者中的应用情况。
J Clin Med. 2025 Jan 22;14(3):687. doi: 10.3390/jcm14030687.
5
Naturally acquired adaptive immunity to is impaired in rheumatoid arthritis patients.类风湿关节炎患者对[具体内容缺失]的自然获得性适应性免疫受损。
Clin Transl Immunology. 2024 Oct 15;13(10):e70012. doi: 10.1002/cti2.70012. eCollection 2024.
6
Efficacy analysis of clinical serological indicators in the diagnosis of postoperative periprosthetic joint infection in patients with rheumatoid arthritis or osteoarthritis.类风湿关节炎或骨关节炎患者人工关节置换术后假体周围感染诊断中临床血清学指标的疗效分析
Int Orthop. 2024 Aug;48(8):1945-1952. doi: 10.1007/s00264-024-06171-y. Epub 2024 Apr 6.
7
Time-varying risks of infection in patients as they proceed through the phases of 'pre-RA': results from the Scottish Early RA inception cohort.患者在“类风湿关节炎前期”各阶段进展过程中感染风险的时变特征:来自苏格兰早期类风湿关节炎队列研究的结果。
RMD Open. 2023 Nov 23;9(4):e003224. doi: 10.1136/rmdopen-2023-003224.
8
Incidence of infections in patients with psoriatic arthritis and axial spondyloarthritis treated with biological or targeted disease-modifying agents: a systematic review and meta-analysis of randomised controlled trials, open-label studies and observational studies.生物制剂或靶向治疗药物治疗的银屑病关节炎和中轴型脊柱关节炎患者的感染发生率:随机对照试验、开放标签研究和观察性研究的系统评价和荟萃分析。
RMD Open. 2023 Sep;9(3). doi: 10.1136/rmdopen-2023-003064.
9
The Intersection of COVID-19 and Rheumatoid Arthritis: Shared Mechanisms, Treatment Challenges, and Potential Therapeutic Approaches.2019冠状病毒病与类风湿性关节炎的交叉点:共同机制、治疗挑战及潜在治疗方法
Aging Dis. 2023 Aug 1;14(4):1196-1213. doi: 10.14336/AD.2023.0406.
10
The prognostic impact of rheumatoid arthritis in sepsis: a population-based analysis.类风湿关节炎在脓毒症中的预后影响:一项基于人群的分析。
Acute Crit Care. 2022 Nov;37(4):533-542. doi: 10.4266/acc.2022.00787. Epub 2022 Oct 6.

本文引用的文献

1
Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapy.类风湿关节炎的治疗与肺炎住院风险:与泼尼松、改善病情抗风湿药及抗肿瘤坏死因子治疗的关联
Arthritis Rheum. 2006 Feb;54(2):628-34. doi: 10.1002/art.21568.
2
The effects of tobacco smoking and rheumatoid factor seropositivity on disease activity and joint damage in early rheumatoid arthritis.吸烟和类风湿因子血清阳性对早期类风湿关节炎疾病活动度和关节损伤的影响。
Rheumatology (Oxford). 2006 Jun;45(6):734-40. doi: 10.1093/rheumatology/kei240. Epub 2006 Jan 10.
3
Pneumocystis carinii pneumonia in Hong Kong: a 10 year retrospective study.香港卡氏肺孢子虫肺炎:一项10年回顾性研究。
J Med Microbiol. 2006 Jan;55(Pt 1):85-88. doi: 10.1099/jmm.0.45893-0.
4
Infections and SLE.感染与系统性红斑狼疮
Autoimmunity. 2005 Nov;38(7):473-85. doi: 10.1080/08916930500285352.
5
Infections in patients with rheumatoid arthritis treated with biologic agents.接受生物制剂治疗的类风湿关节炎患者的感染
Arthritis Rheum. 2005 Nov;52(11):3403-12. doi: 10.1002/art.21386.
6
Immunogenetics of severe respiratory infections: models for the development of new therapeutic strategies.严重呼吸道感染的免疫遗传学:新治疗策略开发的模型
Respiration. 2005 Sep-Oct;72(5):449-57. doi: 10.1159/000087666.
7
Association between smoking and tuberculosis infection: a population survey in a high tuberculosis incidence area.吸烟与结核感染之间的关联:一项在结核病高发病率地区开展的人群调查
Thorax. 2005 Jul;60(7):555-7. doi: 10.1136/thx.2004.030924.
8
Minimization of immunosuppressive therapy after renal transplantation: results of a randomized controlled trial.肾移植后免疫抑制治疗的最小化:一项随机对照试验的结果
Am J Transplant. 2005 Jan;5(1):87-95. doi: 10.1111/j.1600-6143.2004.00638.x.
9
Serious infections associated with anticytokine therapies in the rheumatic diseases.风湿性疾病中与抗细胞因子疗法相关的严重感染。
J Intensive Care Med. 2004 Nov-Dec;19(6):320-34. doi: 10.1177/0885066604267854.
10
Death rates and causes of death in patients with rheumatoid arthritis: a population-based study.类风湿关节炎患者的死亡率及死亡原因:一项基于人群的研究。
Scand J Rheumatol. 2004;33(4):221-7. doi: 10.1080/03009740410005845.